Cryo-Save Group NV - Transaction in Own Shares

* Reuters is not responsible for the content in this press release.

Thu Apr 10, 2008 2:01am EDT 

RNS Number:0318S
Cryo-Save Group NV
10 April 2008



Cryo-Save Group N.V.


Transaction in Own Shares / Total Voting Rights

Cryo-Save Group N.V. (the "Company") yesterday acquired 25,000 of its ordinary
shares at an average price of 154 pence per ordinary share. The ordinary shares
purchased will be held in treasury by the Company.

Following the purchase of these shares, the Company holds 1,110,000 of its
ordinary shares in treasury and has 47,085,986 ordinary shares in issue
(excluding treasury shares).

Shareholders may use the above figure (47,085,986 ordinary shares) as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FSA's Disclosure and Transparency Rules.


Contact details:

Cryo-Save Group                                           + 31 (0) 575 548998
Rob Koremans, Chief Executive
Arnoud van Tulder, Chief Financial Officer


Kaupthing Singer & Friedlander Capital Markets            + 44 (0) 20 3205 7500
Jos Trusted/Marc Young


College Hill                                              + 44 (0) 20 7457 2020
Adrian Duffield/Jon Davies




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

POSSSFFUUSASEEL
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.